A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : mpMRI / multiparametric magnetic resonance imaging

[Related PubMed/MEDLINE]
Total Number of Papers: 729
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   mpMRI  (>> Co-occurring Abbreviation)
Long Form:   multiparametric magnetic resonance imaging
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A 3D/2D Hybrid U-Net CNN approach to prostate organ segmentation of mpMRI. CNN
2020 A deep learning methodology for improved breast cancer diagnosis using multiparametric MRI. AUCs, CNN, DCE, ROC, T2W
2020 A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance Imaging. csPCa
2020 A non-randomized prospective study on the diagnostic performance of perineal prostatic biopsy, directed via diffusion nuclear resonance, in patients with suspected prostate cancer and previous negative transrectal prostate biopsy. PCa, PSA, TPUS-GB, TRUS-GB
2020 A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings. AS, AUC, csPCa, EAU, ECE, GG, ISUP, JH, PCa, PI-RADS, pN, PRIAS, PSAD, pT, RP
2020 A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma. ADC, CRT, DCE-MRI, DW-MRI, SCCAC, SD
2020 Accuracy of Sampling PI-RADS 4-5 Index Lesions Alone by MRI-guided In-bore Biopsy in Biopsy-naive Patients Undergoing Radical Prostatectomy. GG, PCa, PI-RADS, RP
2020 Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort. AS, GG, PCa, PSA
2020 Additional Value of Dynamic Contrast-enhanced Sequences in Multiparametric Prostate Magnetic Resonance Imaging: Data from the PROMIS Study. DCE, TPM
10  2020 Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies. PCa, SB, TB
11  2020 Advanced zoomed diffusion-weighted imaging vs. full-field-of-view diffusion-weighted imaging in prostate cancer detection: a radiomic features study. ADC, AUC, f-DWIb1500, PCa, z-DWIb1500
12  2020 Applications of Artificial Intelligence to Prostate Multiparametric MRI (mpMRI): Current and Emerging Trends. ML
13  2020 Association between PSA density and prostate cancer in men without significant MRI lesions. ---
14  2020 Automatic intraprostatic lesion segmentation in multiparametric magnetic resonance images with proposed multiple branch UNet. ADC, DSC, DWI, MB-UNet, PI-RADS, T2W
15  2020 Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators. csPCs, ERSPC-RC, MRI, PC, PSAD
16  2020 Can clinical radiomics nomogram based on 3D multiparametric MRI features and clinical characteristics estimate early recurrence of pelvic chondrosarcoma? ACC, AUC, CET1 -w, CS, DWI, ER, OR, T1 -w, T2 -w
17  2020 Can multiparametric magnetic resonance of the prostate avoid biopsies in patients with elevated PSA and surgical indication for benign prostatic enlargement? BPE, CsPCa
18  2020 Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy. CEUS, PCa, TRES
19  2020 Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review. AS, CI, PRISMA
20  2020 Characteristics of Cancer Progression on Serial Biopsy in Men on Active Surveillance for Early-stage Prostate Cancer: Implications for Focal Therapy. AS, DT, FT, GG
21  2020 Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center. AS, CS, MVA, PCa, PI-RADS, PRIAS
22  2020 Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer. GG, PCa
23  2020 Clinical utility of combined T2-weighted imaging and T2-mapping in the detection of prostate cancer: a multi-observer study. FSE, ICC, NPVs, PPVs, PZ, Sn, Sp, TZ
24  2020 Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice. CS, IL, MRI-IL, PCa, PI-RADSv2
25  2020 Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population. CSPC, NPV, PHI, PI-RADSv2, PPV
26  2020 Comparison of 68Ga-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and multi-parametric magnetic resonance imaging (MRI) in the evaluation of tumor extension of primary prostate cancer. ECE, MRI, NPV, PET/CT, PPV, PSMA, SVI
27  2020 Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study. BNI, ECE, LNM, PCa, RP, SVI
28  2020 Comparison of clinically significant prostate cancer detection by MRI cognitive biopsy and in-bore MRI-targeted biopsy for naive biopsy patients. COG, IB, PCa
29  2020 Comparison of Histogram-based Textural Features between Cancerous and Normal Prostatic Tissue in Multiparametric Magnetic Resonance Images. ADC, AUC, DW, MANOVA, PZ, T2W
30  2020 Comparison of micro-ultrasound and multiparametric magnetic resonance imaging for prostate cancer: A multicenter, prospective analysis. NPV, PPV
31  2020 Comparison of multiple abbreviated multiparametric MRI-derived protocols for the detection of clinically significant prostate cancer. CDR, cesMRI, csPCa, DCE, FDR, PI-RADSv2, RP, sMRI
32  2020 Concordance Between Biopsy and Radical Prostatectomy Pathology in the Era of Targeted Biopsy: A Systematic Review and Meta-analysis. CI, OR, PRISMA, QUADAS-2
33  2020 Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up. AS, B-PFS, PFS, RP
34  2020 Conspicuity of prostate cancer on multiparametric magnetic resonance imaging: A cross-disciplinary translational hypothesis. ---
35  2020 Correlation of Prostate-Imaging Reporting and Data Scoring System scoring on multiparametric prostate magnetic resonance imaging with histopathological factors in radical prostatectomy material in Turkish prostate cancer patients: a multicenter study of the Urooncology Association. PCa, PI-RADS, RP
36  2020 Could Bladder Multiparametric MRI Be Introduced in Routine Clinical Practice? Role of the New VI-RADS Score: Results From a Prospective Study. CI, MIBC, NMIBC, TURB, VI-RADS
37  2020 Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities. CSPC, TRUS
38  2020 Deep learning-based fully automated detection and segmentation of lymph nodes on multiparametric-mri for rectal cancer: A multicentre study. auto-LNDS, DSC, DWI, LNs, PPV, RC, T2WI
39  2020 Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. PI-RADSv2, PZ, TZ
40  2020 Detection of clinically significant prostate cancer in biopsy-naive men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy. csPCa, CUDI, GG
41  2020 Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography-fusion Biopsy. MRI, PC, SBs, sPC, TBs, TRUS, TS
42  2020 Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy. AUC, CI, EPE, ISUP, PSA, RP
43  2020 Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice. bpMRI, csPCa, DCE
44  2020 Diagnostic Accuracy of Multiparametric MRI for Local Staging of Bladder Cancer: A Systematic Review and Meta-Analysis. UBC
45  2020 Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRI. DRs, PCa, RP, RT
46  2020 Do patients who undergo multiparametric MRI for prostate cancer benefit from additional staging imaging? Results from a statewide collaborative. BS, BVC, CT, LN
47  2020 Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆. CI, CR, EFS, IQR, NAC, OS, RC, RFS
48  2020 DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations. ADC, AS, ICC, PCa
49  2020 Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone. AUC, OR, PSA
50  2020 Effect of pelvimetric diameters on success of surgery in patients submitted to robot-assisted perineal radical prostatectomy. R-PRP
51  2020 Effects of "real life" prostate MRI inter-observer variability on total needle samples and indication for biopsy. MRGpB, PI-RADS
52  2020 Effects of the addition of quantitative apparent diffusion coefficient data on the diagnostic performance of the PI-RADS v2 scoring system to detect clinically significant prostate cancer. ADC, csPCa, PI-RADSv2
53  2020 Evolution of Targeted Prostate Biopsy by Adding Micro-Ultrasound to the Magnetic Resonance Imaging Pathway. csPCa, ISUP, micro-US, MRI, PCa, PRI-MUS
54  2020 Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol. ---
55  2020 External validation of novel magnetic resonance imaging-based models for prostate cancer prediction. AUC, ERSPC, PCa, PI-RADS, ROC
56  2020 External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study. LNI
57  2020 Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review. CAD, csPCa, PI-RADS
58  2020 False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naive Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS. ADC, MRI, PROMIS, PSA, TPM
59  2020 Financial implications of biparametric prostate MRI. bpMRI, DCE
60  2020 Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. AS, CI, EFS, MRI, PY, TFS, UCLH
61  2020 Focal therapy for localized prostate cancer in the era of routine multi-parametric MRI. HIFU
62  2020 Fully Automatic Calibration of Tumor-Growth Models Using a Single mpMRI Scan. GBM, PDE, TIL
63  2020 Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis. MRI, PRISMA, PTEN
64  2020 Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer. CAPRA, ISUP, LNM, MSKCC, PI-RADS, PLND, RALP
65  2020 Histological findings of totally embedded robot assisted laparoscopic radical prostatectomy (RALP) specimens in 1197 men with a negative (low risk) preoperative multiparametric magnetic resonance imaging (mpMRI) prostate lobe and clinical implications. ISUP, PI-RADS, RALP
66  2020 Histomorphological analysis of false positive PI-RADS 4 and 5 lesions. ROI, SB, TB
67  2020 Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma. AUC, PsP, TP
68  2020 How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy. csPCa, GG
69  2020 How Often Does Magnetic Resonance Imaging Detect Prostate Cancer Missed by Transrectal Ultrasound? AS, GG, IQR, PCa, PI-RADS, TRUS
70  2020 How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naive men with PI-RADs v2 score ≤ 3? AUC, CIPCa, csPCa, NPV, PCa, PI-RADSv2, PSA, PSAD, PV, ROC
71  2020 Imaging protocols for renal multiparametric MRI and MR urography: results of a consensus conference from the French Society of Genitourinary Imaging. MRU
72  2020 Imaging quality and prostate MR: it's time to improve. PI-QUAL
73  2020 Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening. PCa, PSA
74  2020 Impact of preoperative prostate magnetic resonance imaging on the surgical management of high-risk prostate cancer. HRPC
75  2020 Impact of surgically maximized versus native membranous urethral length on 30-day and long-term pad-free continence after robot-assisted radical prostatectomy. MUL, RARP
76  2020 Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice. CI, MPS, OR, PCPTrc
77  2020 Improved detection and reduced biopsies: the effect of a multiparametric magnetic resonance imaging-based triage prostate cancer pathway in a public teaching hospital. csPCa, stTPB
78  2020 Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy features. AUC, GG, IRC, OUD, TB
79  2020 Incidentalomas of the prostate detected by 18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. FDG PET, PCa, PSA
80  2020 Incremental Value of Ga-68 Prostate-Specific Membrane Antigen-11 Positron-Emission Tomography/Computed Tomography Scan for Preoperative Risk Stratification of Prostate Cancer. PC, PET/CT
81  2020 Independent external validation of nomogram to predict extracapsular extension in patients with prostate cancer. ECE, GCN, PCa, RP
82  2020 Initial experience with SelectMDx in the diagnosis of prostate cancer in a real-world evidence clinical practice setting. CS-PC, PB, PC
83  2020 Integrated Biophysical Modeling and Image Analysis: Application to Neuro-Oncology. CNS, WHO
84  2020 Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay. ADC, AUC, EHR, IRIS, mpRad
85  2020 Intraindividual comparison between 68Ga-PSMA-PET/CT and mpMRI for intraprostatic tumor delineation in patients with primary prostate cancer: a retrospective analysis in 101 patients. GTV, PCa, PSMA-PET
86  2020 Is dynamic contrast enhancement still necessary in multiparametric magnetic resonance for diagnosis of prostate cancer: a systematic review and meta-analysis. bpMRI, DCE, PCa
87  2020 Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate? CI, cisPCa, COG-TB, csPCa, FUS-TB, MRI, PCa, PI-RADS, SBs, TBs
88  2020 Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece. PB, PCa, RP, SS
89  2020 Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer. CCL, IQR, PI-RADS, ROC
90  2020 Mischievous malakoplakia: A potential pitfall of mpMRI of the prostate? ---
91  2020 MRI for clinically suspected prostate cancer-the disparity between private and public sectors. PCa
92  2020 MRI of Bladder Cancer: Local and Nodal Staging. BC, LN, TURBT, UUT, VI-RADS
93  2020 MRI-targeted biopsy versus standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis of randomized controlled trials. PCa, RCTs
94  2020 MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naive patients: follow-up of a PRECISION trial-like retrospective cohort. csPCa, GG, SB, TB
95  2020 MRI-targeted prostate biopsy: key considerations for pathologists. ---
96  2020 MRI/TRUS FUSION guided biopsy as first approach in ambulatory setting: Feasibility and performance of a new fusion device. csPCa, DR, MRI/TRUS, PSA
97  2020 Multiparametric deep learning tissue signatures for a radiological biomarker of breast cancer: Preliminary results. AUC, DCE, DS, MPDL, SAE-SVM, SSAE
98  2020 Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer. AS, NPV
99  2020 Multiparametric magnetic resonance imaging and multiparametric magnetic resonance imaging-guided biopsy in the diagnostic pathway of prostate cancer. ---
100  2020 Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. CR, MRI